Skip to content

Efficacy of Percutaneous Nephrolithotomy (PCNL)

Efficacy of Percutaneous Nephrolithotomy (PCNL) to resolve symptoms in patients with Nephrolithiasis: A Prospective Observational Analytical study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/12/048542
Enrollment
30
Registered
2022-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney

Interventions

Intervention1: nil: nil

Sponsors

All India Institute of Medical Sciences, Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients aged 18 years and above, eligible for PCNL

Exclusion criteria

Exclusion criteria: a) Patients not consenting to participate in the study. b) Patients with bilateral stones c) Patients with recurrent stones d) Patients with residual stones e) Patients with mental impairment

Design outcomes

Primary

MeasureTime frame
The proportion of patients with chronic symptoms 3 months after the surgery.Timepoint: 3 months

Secondary

MeasureTime frame
1. The proportion of patients with flank pain at post-operative 3 months 2. The proportion of patients with dysuria at post-operative 3 months 3. The proportion of patients with anorexia and nausea at post-operative 3 months 4. The proportion of patients with emotional distress and anxiety at post-operative 3 months 5. The proportion of patients with interference with work at post-operative 3 months 6. The proportion of patients with interference in activities of the daily routine at post-operative 3 months Timepoint: 3 months postoperatively

Countries

India

Contacts

Public ContactDr Swarnendu Mandal

All India Institute of Medical Sciences, Bhubaneswar

urol_swarnendu@aiimsbhubaneswar.edu.in8800254687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026